Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
April 04, 2024 07:30 ET
|
Trinity Biotech plc
DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics,...
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
March 28, 2024 18:39 ET
|
Trinity Biotech plc
DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and...
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
March 08, 2024 10:03 ET
|
Trinity Biotech plc
DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal notification from The Nasdaq Stock Market LLC...
Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
February 15, 2024 12:34 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective date of its ratio change of its American...
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
February 13, 2024 09:00 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it plans to change the ratio of the American depositary shares (“ADSs”)...
Trinity Biotech to Present at Emerging Growth Conference
February 08, 2024 08:30 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present virtually at the Emerging Growth Conference on...
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code
February 07, 2024 08:30 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based reference laboratory, Immco Diagnostics, has applied...
Trinity Biotech Announces Q3 2023 Financial Results & Business Update
January 31, 2024 07:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) today announced the Company’s results for the quarter ended September 30, 2023. Business Updates and Strategic...
Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India
January 31, 2024 07:02 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has entered into a non-binding Letter of Intent with Bayer for the...
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
January 31, 2024 07:00 ET
|
Trinity Biotech plc
-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management -Upfront payment of $12.5 million...